Increased circulating platelet microparticles as a potential biomarker in asthma

D. Duarte*, T. Taveira-Gomes, O. Sokhatska, C. Palmares, R. Costa, R. Negrão, J. T. Guimarães, L. Delgado, R. Soares, A. Moreira

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Abstract

Background Endothelial (EMPs) and platelet microparticles (PMPs) have been studied as biomarkers in several inflammatory diseases and as central players in intercellular communication. Methods In this cross-sectional study, we aimed to assess microparticle levels in asthma. Circulating microparticles and inflammatory and angiogenic markers were assessed by clinical and laboratorial evaluation, flow cytometry, and immunoassays, in a group of 20 asthmatic and 15 nonasthmatic subjects. Results Circulating levels of PMPs (either CD31+/42b+ or CD31+/42b+/AnV+) were significantly increased in asthmatics (P = 0.021) even after adjustment for confounders. Apoptotic EMPs (CD31+/42b - /AnV+) were significantly increased before (P = 0.005) but not after adjustments (P = 0.117). Conclusions We propose that PMPs may be putative asthma biomarkers, playing a role in asthma pathophysiology.

Original languageEnglish
Pages (from-to)1073-1075
Number of pages3
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume68
Issue number8
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Keywords

  • apoptosis
  • asthma
  • endothelial and platelet microparticles
  • sICAM-1
  • VEGF

Fingerprint

Dive into the research topics of 'Increased circulating platelet microparticles as a potential biomarker in asthma'. Together they form a unique fingerprint.

Cite this